Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan
· Delayed Price · Currency is JPY 2,438.00
-23.00 (-0.93%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Skin Care | 190.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Skin Care Growth | 7.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eye Care | 55.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eye Care Growth | 4.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Medication | 49.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Medication Growth | 59.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 13.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 33.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 13.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 33.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Other | 3.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 20.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 164.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 5.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 100.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 27.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America | 20.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America Growth | 11.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 19.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 38.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 3.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 20.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|